Presbyopia Completed Phase 3 Trials for Pilocarpine (DB01085)

Back to Presbyopia

Also known as: Presbyopias

IndicationStatusPhase
DBCOND0001183 (Presbyopia)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04983589A Study to Assess Safety and Efficacy in Participants Age 40 to 55 With Presbyopia (Old Eye) Who Receive AGN-190584 in Both Eyes Twice DailyTreatment
NCT03804268Efficacy Study of Pilocarpine HCl Ophthalmic Solution (AGN-190584) in Participants With PresbyopiaTreatment
NCT03857542A Phase 3 Efficacy Study of Pilocarpine HCl Ophthalmic Solution (AGN-190584) in Participants With PresbyopiaTreatment
NCT04657172Safety & Efficacy of Pilocarpine Eye Solutions for Temporary Improvement of Near Vision in Presbyopic AdultsTreatment